Like CBD (Cannabidiol), CBG (Cannabigerol) is a cannabinoid, a naturally occurring compound that is present in hemp plants. There are hundreds cannabinoids in these plants. CBG is the precursor from which all other cannabinoids are synthesized, which is why it’s often referred to as the “mother” or “stem cell” of cannabinoids. CBG has emerged in research studies to suggest a wide range of possible therapeutic benefits, including potential as an analgesic, anti-inflammatory, neuroprotective, and anti-convulsant, in addition to numerous other potentially positive effects on the human body’s endocannabinoid system

The endocannabinoid system (ECS) is a widespread neuromodulator network involved in the central nervous system and it plays a major role in cognitive and physiological processes. The ECS is composed of endogenous cannabinoids, cannabinoid receptors, and the enzymes responsible for the synthesis and degradation of endocannabinoids.  Cannabinoids and endocannabinoids are mediated by  CB(1) and CB(2) receptors. CB(1) receptors are present in very high levels within the brain and in low amounts in the bodies organs.  

The ECS is  involved in several pathophysiological diseases such as cancer, cardiovascular diseases, and neurodegenerative diseases. In recent years, genetic and pharmacological manipulation of the ECS has gained significant interest in medicine, research, and drug discovery and development. 



• Potent anti-inflammatory agent that may relieve pain.

• May promotes restful Sleep.

• May work as a natural muscle relaxant.

• May have antidepressant and anti-anxiety properties.

• Has antibacterial, antifungal, and antimicrobial properties. (studies showing it may treat MRSA)

• May have a Neuroprotective effect. Currently being evaluated for its ability to combat ailments like Huntington’s and Alzheimer’s Disease.

• CBG may have anti-tumor effects.

• May help manage psoriasis and other inflammatory skin conditions.

• CBG may assist in the treatment of glaucoma.